A De Vito, V Fiore, A Colpani, B Zauli… - Eur. Rev. Med …, 2023 - europeanreview.org
Dalbavancin is a novel long-acting semi-synthetic lipoglycopeptide. It is licensed for acute
bacterial skin and skin structure infections (ABSSSI) caused by susceptible Gram-positive …